The Cleveland Clinic

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, The Cleveland Clinic sits in the top decile of US sponsors by registered trial count (#50 of 15,742 sponsors by registered trial count).

688 total trials 99 currently recruiting 437 completed top decile by trial count

The Cleveland Clinic: 688 sponsored US clinical trials, 99 recruiting.

The Cleveland Clinic sponsors 688 registered US clinical trials on ClinicalTrials.gov, 99 of them currently recruiting, and 437 completed. 81 of these trials are in Phase 3-4 (later-stage) and 76 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Fibrillation, with 9 trials.

Top-decile sponsor footprint

The Cleveland Clinic ranks in the top decile of sponsors by registered trial count (#50 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 42/100

437 of 539 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

688 total, page 5 of 14

COMPLETED NA

Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing

NCT04706299

COMPLETED Phase 4

Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity

NCT04614545

COMPLETED Phase 3

Postoperative Consequences of Intraoperative NOL Titration

NCT04679818

TERMINATED NA

Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients

NCT04748120

TERMINATED Phase 4

Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery

NCT04561375

COMPLETED Phase 2

Dual-task Augmented Reality Treatment for Parkinson's Disease

NCT04634331

COMPLETED

Synbiotic Dietary Supplement and Gut Microbiota

NCT04097106

TERMINATED Phase 1

Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)

NCT04543994

COMPLETED Phase 3

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:

NCT04501861

TERMINATED Phase 1

Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis

NCT04548583

TERMINATED Phase 4

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

NCT04567225

COMPLETED NA

Pelvic Floor Physical Therapy vs Standard Care in Transgender Women Undergoing Vaginoplasty for Gender Affirmation

NCT05690555

TERMINATED Phase 4

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

NCT04531176

COMPLETED NA

STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial

NCT04491617

COMPLETED NA

Cooling Vest May Reduce Heat Stress During Surgery

NCT04511208

COMPLETED NA

Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients

NCT04603417

COMPLETED NA

Patient Priority Care for Older Adults With Multiple Chronic Conditions

NCT04510948

COMPLETED NA

Virtual Reality Distraction for Reduction

NCT04416555

TERMINATED NA

Role of Blood Management in Perioperative Outcomes

NCT04475497

COMPLETED

Parallel Mapping for Ventricular Tachycardia

NCT04477499

COMPLETED

Prevention of Opioid-Induced Hypoxemia

NCT04453722

COMPLETED NA

Rhythmic Auditory Stimulation & Gait Training

NCT04314076

COMPLETED NA

Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.

NCT04415879

COMPLETED Phase 2

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

NCT04399980

COMPLETED Phase 2

Canakinumab in Covid-19 Cardiac Injury (The Three C Study)

NCT04365153

COMPLETED Phase 4

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

NCT04411693

COMPLETED NA

Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation

NCT04342728

COMPLETED Phase 2

Post-Operative Constipation Following Total Knee Arthroplasty

NCT04380090

COMPLETED NA

Cleveland Clinic Families Get Fit (CCFit) : A Family-based Activity-Monitor Intervention in Pediatric Obesity

NCT04312919

TERMINATED NA

STandardized Ultra-conservative Or Physician-directed ICD Programming for Continuous Flow LVAD Support

NCT04264182

COMPLETED NA

Modulatory Effects of Deep Brain Stimulation on Cerebral Cortical Activity

NCT04361955

COMPLETED NA

Novel Paradigms of Deep Brain Stimulation for Movement Disorders

NCT04563143

TERMINATED

Novel Quantitative MRI for Axial Spondyloarthritis

NCT03778515

COMPLETED NA

The Impact of Combined Mindfulness-Based Interventions and Nutritional Counseling on Physician Burnout

NCT04336436

COMPLETED NA

Pragmatic Cyclical Lower Extremity Exercise Trial for Parkinson's Disease

NCT04000360

COMPLETED

Validation Study for the Alertgy Non-invasive Continuous Glucose Monitor (ANICGM)

NCT04166032

COMPLETED NA

Comparing eTEP and Laparoscopic Intraperitoneal Onlay Mesh (IPOM) for Ventral Hernias

NCT04150796

COMPLETED NA

Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation

NCT03938688

COMPLETED Phase 2

Pomalidomide for the Treatment of Bleeding in HHT

NCT03910244

TERMINATED NA

Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients

NCT04116684

COMPLETED NA

Tracking Device Guided Feedback to Enhance Patient Physician Interaction

NCT04004806

COMPLETED NA

Feasibility Study for Intrathoracic Nerve Stimulation

NCT04066374

COMPLETED

Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant

NCT04340505

COMPLETED NA

Virtual Visits to Optimize Research Trial Offerings to HF Patients

NCT04064541

COMPLETED NA

Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis

NCT04000373

COMPLETED Phase 1

Improving SCI Rehabilitation Interventions by Retraining the Brain

NCT03892746

COMPLETED Phase 3

Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome

NCT03879538

COMPLETED

Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes

NCT03955952

COMPLETED NA

Comparison of Lithotripsy Urolithiasis Machines

NCT04069338

COMPLETED NA

A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch

NCT03986281

← Previous Page 5 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 38
Phase 2 38
Phase 3 22
Phase 4 59

What is open in the The Cleveland Clinic pipeline

99 recruiting of 688 indexed (14% open); 437 completed (64%).

Phase mix: 81 late (III/IV) vs 76 early (I/II) (balanced across stages).

Top condition: Atrial Fibrillation (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The Cleveland Clinic: open-pipeline peers nationwide

Peers matched on 688 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

The Cleveland Clinic sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 5%10%15%20%25% Total trials Recruiting share The Cleveland ClinicVanderbilt University Medical CenterWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiSanofiDana-Farber Cancer InstituteModernaTXMasonic Cancer Center, University of MinnesotaAcademic and Community Cancer Research United
The Cleveland Clinic sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The Cleveland Clinic sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 688 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this The Cleveland Clinic page

688 registered trials is a research-attention snapshot, not an endorsement of The Cleveland Clinic or any single study.

  • 99 of The Cleveland Clinic's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Atrial Fibrillation is the condition The Cleveland Clinic studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The Cleveland Clinic pipeline card: 688 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.